MedPath

A Clinical trial to study the effect of the Drug Maampisin Chooranam in patients having excessive and prolonged menstrual bleeding (Menorrhagia)

Phase 2
Conditions
Health Condition 1: null- FEMALE WITH EXCESSIVE AND PROLONGED MENSTRUATIO
Registration Number
CTRI/2018/03/012381
Lead Sponsor
Government Siddha Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age 15 to 50 years

Willing to participate in trial and signing in consent proforma

complaints of excessive and prolonged menstruation

Perimenopausal Menorrhagia

Puberty Menorrhagia

Anaemia due to Menorrhagia

Menorrhagia in PCOD

Exclusion Criteria

Fibroid polyp

Chocolate cysts

Ovarian feminizing tumour

Hypothyroidism

Bleeding disorders

Patients having IUCD

Uterine fibroid

Adenomyosis

Abortion and Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Outcome is mainly assessed by reduction in clinical symptoms and by comparing the following parameters before and after treatment. <br/ ><br>Reduced amount of blood flow is assessed by number of sanitary pads used before and after treatment. <br/ ><br>Timepoint: 48 days
Secondary Outcome Measures
NameTimeMethod
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 48 days
© Copyright 2025. All Rights Reserved by MedPath